Key facts
- Notable investors include LifeX Ventures, National Science Foundation Innovation Corps Program.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Netramind Innovations
- ·The full record, as it builds
Funding rounds
No funding rounds for Netramind Innovations are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Netramind Innovations
Developer of an AI-powered ophthalmic image-analysis tool designed to improve ophthalmology and enhance patient care. The company provides AI-powered ophthalmic data analysis, screening, and prediction, including advanced image analysis for choroid boundary detection, three-dimensional vasculature visualization, thickness heatmaps, and multimodal image registration, providing clinicians with improved diagnostic insight, earlier disease detection, and more personalized treatment planning for better patient outcomes.
- Sector
- Healthcare
- HQ
- Pittsburgh, PA, United States
- Founded
- 2024
- Employees
- 6
- Website
- netramindinnovations.com/
- Ownership
- Privately Held (backing)
Netramind Innovations doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Netramind Innovations shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Netramind Innovations in its N-PORT filings yet. We sweep new filings monthly.